Primary study · included by 1 review

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Kumar 2008b · Kumar Bhavna, Cordell Kitrina G, Lee Julia S, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2008

Included by

Prognostic Value of Bcl-xL in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Kumar 2008b · Table 1; References; Table S1

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall survival High tumoral Bcl-xL expression vs Low tumoral Bcl-xL expression	HR 1.12 [0.95, 1.32]	3 studies · 236 participants	GRADE not reported

1 including review in total.